Pet allergy medication for humans encompasses a range of treatments designed to control the immune response triggered by animal dander, saliva, and urine proteins. In the UK, pet allergies are among the most common causes of allergic rhinitis, affecting a significant number of adults and often co-existing with asthma. Symptoms — from sneezing and itchy eyes to skin rashes and wheeze — can substantially affect daily life. This article outlines NHS-recommended medications, practical home management strategies, and when specialist referral or allergen immunotherapy may be appropriate, helping you make informed decisions about your care.

Understanding Pet Allergies and Their Symptoms in Adults

Pet allergies are caused by proteins in animal dander, saliva, and urine, triggering IgE-mediated symptoms including sneezing, itchy eyes, skin rashes, and wheeze; severe breathing difficulty or anaphylaxis requires immediate emergency care.

Not sure if this is normal? Chat with one of our pharmacists →

Pet allergies are common in the UK, affecting a significant proportion of adults. Contrary to popular belief, the primary trigger is not pet fur itself but rather proteins found in an animal's dander (tiny flakes of skin), saliva, urine, and sebaceous gland secretions. Cats and dogs are the most frequent culprits, though rabbits, guinea pigs, horses, and rodents can also provoke significant allergic responses.

When a sensitised individual is exposed to these proteins, their immune system mistakenly identifies them as harmful, triggering the release of immunoglobulin E (IgE) antibodies and histamine. This immune cascade produces the characteristic symptoms of allergic rhinitis and related conditions. Most IgE-mediated symptoms occur within minutes of exposure, though some individuals may also notice a delayed worsening several hours later. Common symptoms in adults include:

• Sneezing and a runny or blocked nose

• Itchy, red, or watering eyes (allergic conjunctivitis)

• Skin rashes, hives, or eczema flares

• Coughing, wheezing, or shortness of breath, particularly in those with co-existing asthma

• Itching of the throat, mouth, or skin

Symptoms can range from mild and intermittent to persistent and debilitating, significantly affecting quality of life, sleep, and productivity. It is worth noting that similar symptoms can also be caused by non-allergic rhinitis, so an accurate diagnosis is important before committing to long-term treatment.

If you develop severe breathing difficulty or signs of anaphylaxis following pet exposure, call 999 or go to A&E immediately. For persistent or worsening symptoms, a GP can arrange a specific IgE blood test to help confirm sensitisation. Skin prick testing is typically performed in specialist allergy clinics and results should always be interpreted alongside your clinical history. If lower respiratory symptoms such as wheeze or breathlessness are prominent, ensure your asthma is reviewed and well controlled.

NHS-Recommended Medications for Pet Allergies

NICE CKS guidance recommends intranasal corticosteroids as the preferred first-line treatment for persistent allergic rhinitis, with non-sedating oral antihistamines suitable for mild or intermittent symptoms.

The NHS and NICE provide clear guidance on the stepwise management of allergic rhinitis and related conditions, which forms the backbone of pet allergy treatment. The goal of medication is to reduce the inflammatory response triggered by allergen exposure, thereby controlling symptoms and improving daily functioning. The NICE Clinical Knowledge Summary (CKS) on allergic rhinitis and BSACI rhinitis guidelines both support a stepwise approach.

First-line treatments typically include:

• Non-sedating oral antihistamines such as cetirizine, loratadine, or fexofenadine, all of which are available over the counter at pharmacies

• Intranasal corticosteroid sprays such as beclometasone dipropionate or fluticasone propionate, considered the most effective single treatment for persistent allergic rhinitis

• Intranasal antihistamine sprays (e.g., azelastine), which are usually prescription-only but act more rapidly than intranasal corticosteroids and may be useful as an adjunct

• Saline nasal irrigation, which can help clear allergens and reduce mucosal irritation

• Antihistamine eye drops for those with prominent ocular symptoms

For mild, intermittent symptoms, an oral antihistamine taken as needed may be sufficient. For moderate-to-severe or persistent symptoms, NICE CKS guidance recommends intranasal corticosteroids as the preferred first-line option, used regularly rather than on an as-needed basis. These work by reducing local mucosal inflammation and are generally well tolerated with minimal systemic absorption when used correctly.

Important cautions:

• Topical nasal decongestant sprays (e.g., xylometazoline) should not be used for more than 5–7 days, as prolonged use can cause rebound congestion (rhinitis medicamentosa).

• Fexofenadine should not be taken with fruit juice (including grapefruit, orange, or apple juice), as this can significantly reduce absorption. If you take aluminium- or magnesium-containing antacids, separate them from fexofenadine by at least two hours.

Many people underuse intranasal sprays or discontinue them prematurely, reducing their effectiveness. Pharmacists can provide valuable guidance on correct nasal spray technique and appropriate product selection. If over-the-counter options fail to provide adequate relief after two to four weeks of consistent use, a GP review is advisable to explore prescription-strength alternatives or combination therapy.

If you experience a suspected side effect from any allergy medication, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or using the Yellow Card app.

Experiencing these side effects? Our pharmacists can help you navigate them →

Antihistamines, Nasal Sprays and Eye Drops: What to Use

Non-sedating antihistamines (cetirizine, loratadine, fexofenadine) treat sneezing and itch, intranasal corticosteroids address nasal congestion, and ketotifen or sodium cromoglicate eye drops provide first-line relief for allergic conjunctivitis.

Understanding the differences between available treatments helps individuals and clinicians select the most appropriate option for their symptom profile. Each medication class targets a different aspect of the allergic response.

Oral antihistamines block H1 histamine receptors, reducing sneezing, itching, and runny nose. Non-sedating options — cetirizine (10 mg once daily), loratadine (10 mg once daily), and fexofenadine (120 mg once daily for rhinitis) — are preferred over older sedating antihistamines such as chlorphenamine, which can impair concentration and driving ability. Non-sedating antihistamines are generally safe for long-term use, though cetirizine may cause mild drowsiness in some individuals. See the fexofenadine interaction cautions noted above.

Intranasal corticosteroid sprays such as fluticasone propionate or beclometasone dipropionate are highly effective for nasal congestion, sneezing, and rhinorrhoea. They typically take several days of regular use to reach full effect, so consistent daily use is essential. Side effects are generally mild and localised, including nasal dryness or occasional minor nosebleeds. Correct technique — directing the spray towards the outer wall of the nostril and away from the nasal septum — reduces the risk of irritation. A pharmacist can demonstrate correct nasal spray technique.

Intranasal antihistamine sprays (e.g., azelastine nasal spray, prescription-only) act more rapidly than intranasal corticosteroids and may be useful when faster relief is needed. A combination intranasal spray containing both azelastine and fluticasone propionate is available on prescription and may offer superior symptom control for moderate-to-severe cases.

Antihistamine and other eye drops provide targeted relief for allergic conjunctivitis. Over-the-counter options include ketotifen and sodium cromoglicate eye drops, which are suitable first choices. Azelastine and olopatadine eye drops are also effective but are prescription-only in the UK. For more severe ocular symptoms, a GP or ophthalmologist may prescribe additional treatment. Avoid using decongestant eye drops for more than 5–7 days, as rebound redness can occur with prolonged use.

Always consult a pharmacist or GP before combining multiple allergy medications to avoid unnecessary duplication or interactions.

When to Consider Immunotherapy or Specialist Referral

Allergen immunotherapy is the only treatment that modifies underlying allergic disease, but sublingual tablets are not currently licensed in the UK for cat or dog allergens; referral is indicated when symptoms remain poorly controlled despite optimal medication.

For individuals whose pet allergy symptoms remain poorly controlled despite optimal pharmacological management, or where medication use is causing significant side effects or inconvenience, referral to an NHS allergy clinic should be considered. NICE CKS and BSACI guidance support referral when symptoms are persistent, severe, or associated with asthma that is difficult to control.

Allergen immunotherapy (AIT) — sometimes called desensitisation — is the only treatment that can modify the underlying allergic disease rather than simply managing symptoms. It works by gradually exposing the immune system to increasing doses of the relevant allergen, promoting tolerance over time. Two main forms are available:

• Subcutaneous immunotherapy (SCIT): Injections administered in a clinic setting over several years, under medical supervision due to the small risk of systemic reactions

• Sublingual immunotherapy (SLIT): Allergen extracts administered as drops or tablets under the tongue; some regimens can be continued at home after initial supervised doses

Important points about AIT availability and safety in the UK:

• In the UK, allergen immunotherapy products are regulated by the MHRA. Some specialist products for cat allergy are available in certain UK allergy centres, typically on a named-patient or specials basis. Evidence and licensed product availability for dog allergy immunotherapy remain limited in the UK.

• SLIT tablets are licensed in the UK for some pollen and house dust mite allergies, but not currently for cat or dog allergens.

• AIT requires confirmed relevant IgE sensitisation, a clinical history consistent with allergen-driven symptoms, and an assessment that allergen avoidance alone is insufficient.

• AIT should not be initiated in individuals with uncontrolled asthma, and is generally avoided during pregnancy. A thorough assessment by an allergy specialist is essential before starting.

Seek urgent GP review or specialist referral if you experience:

• Poorly controlled asthma triggered by pet exposure

• Recurrent severe allergic reactions

• Significant impact on work, sleep, or mental wellbeing despite medication

• Uncertainty about the specific allergen responsible for your symptoms

A formal allergy assessment can provide clarity and open access to a broader range of treatment options.

Managing Pet Allergies Alongside Medication at Home

Reducing allergen exposure through measures such as excluding pets from bedrooms, using HEPA-filter vacuums, and washing bedding at 60°C significantly enhances the effectiveness of pet allergy medication.

Medication alone is rarely sufficient to achieve optimal control of pet allergies; environmental management strategies are an equally important component of a comprehensive approach. The NHS advises that reducing allergen exposure can significantly enhance the effectiveness of pharmacological treatment and, in some cases, reduce the doses required.

Practical measures to reduce pet allergen exposure at home include:

• Keeping pets out of bedrooms and off soft furnishings such as sofas and carpets, where dander accumulates

• Washing pets regularly — weekly bathing of cats or dogs may reduce airborne allergen levels, though evidence on long-term clinical symptom benefit is mixed and this alone is unlikely to be sufficient

• Using HEPA-filter vacuum cleaners and air purifiers — these can reduce airborne dander particles, though evidence that this translates to consistent symptom improvement varies between individuals

• Washing hands thoroughly after handling pets and avoiding touching the face; consider changing clothes after prolonged contact with animals

• Replacing carpets with hard flooring where possible, as carpets trap allergens more readily

• Regular cleaning and vacuuming of soft furnishings and surfaces to reduce allergen accumulation

• Washing bedding frequently at 60°C, which helps reduce allergen load (this temperature is particularly effective against dust mite allergen and is also useful for reducing pet dander on bedding)

It is also worth considering the emotional and psychological dimensions of pet allergy management. Many people are deeply attached to their pets and find the prospect of rehoming them distressing. A balanced, non-judgemental conversation with a GP or allergy specialist can help explore all available options before such a decision is made.

For those who visit homes with pets rather than owning one, taking a non-sedating antihistamine approximately one hour before exposure can help blunt the allergic response. If you wish to use an intranasal corticosteroid spray prophylactically, note that these require several days of regular use to reach full effect and are not suitable for single-dose pre-exposure use. Intranasal antihistamine sprays (prescription-only) act more rapidly and may be more appropriate for pre-exposure relief — discuss this with your GP or pharmacist. Those with asthma should carry their reliever inhaler.

Finally, review your management plan regularly with a healthcare professional. Allergy symptoms can change over time, and what works well initially may need adjustment. Open communication with your GP or pharmacist ensures that your pet allergy medication remains both safe and effective in the long term.

If you experience a suspected side effect from any allergy medicine, report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or using the Yellow Card app.

Frequently Asked Questions